K
Kane John M
Researcher at Aventis Pharma
Publications - 52
Citations - 523
Kane John M is an academic researcher from Aventis Pharma. The author has contributed to research in topics: Alkyl & Alkoxy group. The author has an hindex of 13, co-authored 52 publications receiving 520 citations. Previous affiliations of Kane John M include Colorado State University & Marion Merrell Dow.
Papers
More filters
Journal ArticleDOI
Total synthesis of (-)-maysine
Albert I. Meyers,K. A. Babiak,Campbell Arthur L,Daniel L. Comins,Michael P. Fleming,Rainer Henning,Manfred Heuschmann,James P. Hudspeth,Kane John M +8 more
Patent
Novel substituted piperidines useful for the treatment of allergic diseases
Burkholder Timothy P,Larry D. Bratton,Kudlacz Elizabeth M,Maynard George D,Kane John M,Braulio Santiago +5 more
TL;DR: In this paper, substituted piperidine derivatives of formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists.
Patent
(+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
TL;DR: In this paper, a new 5HT2 antagonist, (+)-alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophe-nyl)ethyl]-4-piperidinemethanol, and its use in the treatment of a number of disease states was described.
Patent
Antihistaminic piperidinyl benzimidazoles
TL;DR: A new class of piperidinyl benzimidazole antihistamines can be described by the following formula: as discussed by the authors, where Y is represented by CO or CHOH; m is an integer from 1 to 2.
Patent
Piperidinyl thiacyclic derivatives
TL;DR: Piperidinyl thiacyclic derivatives useful in the treatment of allergic diseases and diseases responding to antagonism of 5HT2 receptors, pharmaceutical compositions and methods of treatment using these compounds as discussed by the authors.